William Eugene Butler, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carotid Artery, Internal | 2 | 2021 | 445 | 0.810 |
Why?
|
| Hydrocephalus | 9 | 2020 | 748 | 0.790 |
Why?
|
| Moyamoya Disease | 3 | 2021 | 237 | 0.740 |
Why?
|
| Ventriculostomy | 3 | 2017 | 136 | 0.700 |
Why?
|
| Cerebral Ventricles | 2 | 2020 | 544 | 0.660 |
Why?
|
| Wavelet Analysis | 1 | 2017 | 57 | 0.620 |
Why?
|
| Meningomyelocele | 1 | 2017 | 165 | 0.550 |
Why?
|
| Angiography | 2 | 2017 | 1638 | 0.510 |
Why?
|
| Cerebrospinal Fluid | 1 | 2017 | 534 | 0.490 |
Why?
|
| Motor Skills Disorders | 1 | 2014 | 90 | 0.480 |
Why?
|
| Thoracic Vertebrae | 1 | 2017 | 608 | 0.440 |
Why?
|
| Intracranial Aneurysm | 7 | 2017 | 1197 | 0.370 |
Why?
|
| Arnold-Chiari Malformation | 3 | 2023 | 154 | 0.350 |
Why?
|
| Spondylosis | 3 | 2014 | 81 | 0.330 |
Why?
|
| Myofibromatosis | 1 | 2008 | 30 | 0.330 |
Why?
|
| Cerebrovascular Circulation | 1 | 2017 | 2732 | 0.300 |
Why?
|
| Brachial Plexus Neuropathies | 1 | 2008 | 123 | 0.300 |
Why?
|
| Paralysis | 1 | 2008 | 249 | 0.290 |
Why?
|
| Embolization, Therapeutic | 7 | 2018 | 1392 | 0.280 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1456 | 0.270 |
Why?
|
| Laminectomy | 2 | 2016 | 234 | 0.260 |
Why?
|
| Spondylolisthesis | 2 | 2016 | 163 | 0.240 |
Why?
|
| Aneurysm, Ruptured | 4 | 2015 | 452 | 0.240 |
Why?
|
| Decompression, Surgical | 5 | 2016 | 594 | 0.230 |
Why?
|
| Intracranial Arteriovenous Malformations | 4 | 2015 | 356 | 0.220 |
Why?
|
| Spinal Stenosis | 2 | 2016 | 255 | 0.220 |
Why?
|
| Neurosurgical Procedures | 5 | 2017 | 2003 | 0.220 |
Why?
|
| Endoscopy | 1 | 2012 | 1784 | 0.210 |
Why?
|
| Infratentorial Neoplasms | 1 | 2002 | 94 | 0.200 |
Why?
|
| Third Ventricle | 1 | 2001 | 76 | 0.190 |
Why?
|
| Speech Disorders | 1 | 2021 | 189 | 0.190 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2018 | 145 | 0.180 |
Why?
|
| Stereotaxic Techniques | 2 | 1999 | 535 | 0.170 |
Why?
|
| Cerebral Revascularization | 1 | 2021 | 238 | 0.170 |
Why?
|
| Intracranial Hypertension | 1 | 2001 | 186 | 0.170 |
Why?
|
| Ependymoma | 1 | 2002 | 334 | 0.170 |
Why?
|
| Neurocytoma | 1 | 2018 | 30 | 0.160 |
Why?
|
| Transverse Sinuses | 1 | 2018 | 24 | 0.160 |
Why?
|
| Facial Paralysis | 1 | 2021 | 338 | 0.150 |
Why?
|
| Mobile Health Units | 1 | 1998 | 80 | 0.150 |
Why?
|
| Swine | 2 | 2017 | 5940 | 0.150 |
Why?
|
| Pituitary Neoplasms | 2 | 2021 | 1346 | 0.150 |
Why?
|
| Astrocytoma | 2 | 2016 | 789 | 0.150 |
Why?
|
| Viscosity | 1 | 2017 | 328 | 0.150 |
Why?
|
| Brain | 6 | 2021 | 26413 | 0.150 |
Why?
|
| Diagnosis, Differential | 4 | 2021 | 12961 | 0.140 |
Why?
|
| Lumbar Vertebrae | 2 | 2016 | 1848 | 0.140 |
Why?
|
| Cervical Vertebrae | 2 | 2014 | 975 | 0.140 |
Why?
|
| Respiratory Aspiration | 1 | 2016 | 81 | 0.130 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1996 | 133 | 0.130 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 850 | 0.120 |
Why?
|
| Aneurysm, False | 1 | 2017 | 276 | 0.120 |
Why?
|
| Brain Diseases | 2 | 2023 | 1564 | 0.120 |
Why?
|
| Cerebrospinal Fluid Shunts | 2 | 2006 | 189 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 3 | 2018 | 1475 | 0.120 |
Why?
|
| Intraoperative Care | 1 | 1998 | 767 | 0.120 |
Why?
|
| Radiation Injuries | 2 | 2021 | 1178 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2017 | 1442 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2020 | 838 | 0.120 |
Why?
|
| Craniotomy | 3 | 2015 | 729 | 0.120 |
Why?
|
| Sensation Disorders | 1 | 2014 | 156 | 0.120 |
Why?
|
| Genes, Dominant | 1 | 1996 | 880 | 0.110 |
Why?
|
| Craniopharyngioma | 2 | 2021 | 281 | 0.110 |
Why?
|
| Microsurgery | 1 | 2017 | 796 | 0.100 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
| Spinal Cord Diseases | 1 | 2014 | 299 | 0.100 |
Why?
|
| Rhombencephalon | 1 | 2011 | 85 | 0.100 |
Why?
|
| Male | 35 | 2021 | 350027 | 0.100 |
Why?
|
| Humans | 50 | 2023 | 744220 | 0.100 |
Why?
|
| Fourth Ventricle | 1 | 2011 | 30 | 0.100 |
Why?
|
| Treatment Outcome | 17 | 2021 | 63119 | 0.100 |
Why?
|
| Syringomyelia | 1 | 2011 | 64 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 11 | 2023 | 35423 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2017 | 20123 | 0.100 |
Why?
|
| Decompressive Craniectomy | 1 | 2011 | 72 | 0.100 |
Why?
|
| Cavernous Sinus | 2 | 2002 | 125 | 0.090 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 8860 | 0.090 |
Why?
|
| Neurocysticercosis | 1 | 2011 | 62 | 0.090 |
Why?
|
| Spinal Fusion | 2 | 2016 | 1241 | 0.090 |
Why?
|
| Halogenation | 1 | 2009 | 42 | 0.090 |
Why?
|
| Child | 18 | 2021 | 77679 | 0.090 |
Why?
|
| Chromosome Aberrations | 1 | 1996 | 1814 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 3 | 2015 | 2647 | 0.080 |
Why?
|
| Spinal Cord Compression | 1 | 2011 | 235 | 0.080 |
Why?
|
| Infant | 8 | 2021 | 35129 | 0.080 |
Why?
|
| Stilbenes | 1 | 2009 | 156 | 0.080 |
Why?
|
| Anticarcinogenic Agents | 1 | 2009 | 253 | 0.070 |
Why?
|
| Spinal Cord | 1 | 2016 | 1809 | 0.070 |
Why?
|
| Postoperative Complications | 8 | 2016 | 15294 | 0.070 |
Why?
|
| Arm Injuries | 1 | 2008 | 160 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 9230 | 0.070 |
Why?
|
| Female | 30 | 2021 | 380197 | 0.070 |
Why?
|
| Histones | 1 | 2016 | 2600 | 0.060 |
Why?
|
| Vasospasm, Intracranial | 2 | 2015 | 208 | 0.060 |
Why?
|
| Vision Disorders | 2 | 2021 | 1059 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 1998 | 3680 | 0.060 |
Why?
|
| Endovascular Procedures | 2 | 2015 | 1979 | 0.060 |
Why?
|
| Mutation | 3 | 2020 | 29784 | 0.060 |
Why?
|
| Centralized Hospital Services | 1 | 2004 | 18 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2015 | 1623 | 0.060 |
Why?
|
| Pseudotumor Cerebri | 1 | 2005 | 100 | 0.060 |
Why?
|
| Foramen Magnum | 1 | 2023 | 36 | 0.060 |
Why?
|
| Cysts | 1 | 2009 | 679 | 0.060 |
Why?
|
| Asphyxia | 1 | 2003 | 57 | 0.060 |
Why?
|
| Hearing Disorders | 1 | 2003 | 125 | 0.060 |
Why?
|
| Retinal Hemorrhage | 1 | 2003 | 96 | 0.050 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2004 | 194 | 0.050 |
Why?
|
| Encephalocele | 1 | 2003 | 135 | 0.050 |
Why?
|
| Paresis | 1 | 2003 | 179 | 0.050 |
Why?
|
| Cerebellar Neoplasms | 1 | 2007 | 587 | 0.050 |
Why?
|
| Propionibacterium acnes | 1 | 2001 | 66 | 0.050 |
Why?
|
| Aphasia | 1 | 2003 | 179 | 0.050 |
Why?
|
| Neck Injuries | 1 | 2003 | 152 | 0.050 |
Why?
|
| Aged | 14 | 2018 | 163253 | 0.050 |
Why?
|
| Neurofibromatosis 1 | 1 | 2007 | 568 | 0.050 |
Why?
|
| Adolescent | 15 | 2021 | 85759 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2006 | 1179 | 0.050 |
Why?
|
| Compartment Syndromes | 1 | 2003 | 153 | 0.050 |
Why?
|
| Ataxia | 1 | 2003 | 304 | 0.050 |
Why?
|
| Orbital Diseases | 1 | 2003 | 181 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2014 | 5982 | 0.050 |
Why?
|
| Angioplasty | 1 | 2004 | 364 | 0.050 |
Why?
|
| Thoracic Injuries | 1 | 2003 | 272 | 0.050 |
Why?
|
| Seasons | 1 | 2006 | 1494 | 0.050 |
Why?
|
| Child, Preschool | 10 | 2021 | 40992 | 0.050 |
Why?
|
| Cerebral Angiography | 3 | 2018 | 1285 | 0.050 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2000 | 57 | 0.050 |
Why?
|
| Hospital Mortality | 5 | 2006 | 5316 | 0.050 |
Why?
|
| Retrospective Studies | 14 | 2021 | 77426 | 0.040 |
Why?
|
| Subarachnoid Hemorrhage | 3 | 2015 | 1018 | 0.040 |
Why?
|
| Motor Cortex | 2 | 1997 | 986 | 0.040 |
Why?
|
| Reoperation | 3 | 2017 | 4203 | 0.040 |
Why?
|
| Radiotherapy Dosage | 2 | 2018 | 2878 | 0.040 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 1999 | 68 | 0.040 |
Why?
|
| Glioma | 1 | 2014 | 3401 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2001 | 579 | 0.040 |
Why?
|
| Radiosurgery | 2 | 2000 | 1328 | 0.040 |
Why?
|
| Hydroxyl Radical | 1 | 1999 | 78 | 0.040 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2001 | 341 | 0.040 |
Why?
|
| Specialization | 1 | 2004 | 777 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17449 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 1999 | 190 | 0.040 |
Why?
|
| Radiotherapy, Conformal | 2 | 2014 | 548 | 0.040 |
Why?
|
| Myosins | 1 | 2000 | 409 | 0.040 |
Why?
|
| Animals | 6 | 2017 | 168788 | 0.040 |
Why?
|
| Recurrence | 4 | 2016 | 8343 | 0.040 |
Why?
|
| Middle Aged | 16 | 2018 | 213367 | 0.040 |
Why?
|
| Nausea | 1 | 2021 | 668 | 0.040 |
Why?
|
| Protons | 1 | 2003 | 1127 | 0.040 |
Why?
|
| Vomiting | 1 | 2021 | 635 | 0.040 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 1997 | 1432 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2003 | 819 | 0.040 |
Why?
|
| Hospital Charges | 3 | 2004 | 362 | 0.040 |
Why?
|
| Thermoluminescent Dosimetry | 1 | 1997 | 24 | 0.040 |
Why?
|
| Film Dosimetry | 1 | 1997 | 29 | 0.040 |
Why?
|
| Workload | 1 | 2003 | 850 | 0.040 |
Why?
|
| Vasoconstriction | 1 | 2000 | 597 | 0.040 |
Why?
|
| Balloon Occlusion | 1 | 2017 | 126 | 0.040 |
Why?
|
| Neurosurgery | 2 | 2005 | 643 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 1998 | 498 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2003 | 1525 | 0.030 |
Why?
|
| Adult | 15 | 2018 | 214035 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2018 | 6893 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 977 | 0.030 |
Why?
|
| Syndrome | 1 | 2001 | 3250 | 0.030 |
Why?
|
| Cohort Studies | 7 | 2018 | 40559 | 0.030 |
Why?
|
| Neuroglia | 1 | 2020 | 927 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2021 | 1914 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 57768 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 2014 | 87 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2002 | 3614 | 0.030 |
Why?
|
| Decision Trees | 1 | 1996 | 506 | 0.030 |
Why?
|
| Fatigue | 1 | 2021 | 1531 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 1999 | 1254 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2000 | 1504 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10480 | 0.030 |
Why?
|
| Headache | 1 | 2021 | 1226 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1996 | 515 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2008 | 25618 | 0.030 |
Why?
|
| Confidence Intervals | 1 | 1999 | 2970 | 0.030 |
Why?
|
| Equipment Design | 2 | 1998 | 3582 | 0.030 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39045 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2018 | 1770 | 0.030 |
Why?
|
| Staphylococcal Infections | 1 | 2001 | 1400 | 0.030 |
Why?
|
| Markov Chains | 1 | 1996 | 969 | 0.030 |
Why?
|
| United States | 9 | 2016 | 69867 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2001 | 1540 | 0.030 |
Why?
|
| Actins | 1 | 2000 | 2121 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 2015 | 395 | 0.030 |
Why?
|
| Organs at Risk | 1 | 2014 | 346 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 1999 | 941 | 0.030 |
Why?
|
| Databases as Topic | 2 | 2004 | 475 | 0.030 |
Why?
|
| Arteriovenous Fistula | 1 | 2015 | 315 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2005 | 3265 | 0.020 |
Why?
|
| Pituitary Gland | 1 | 2014 | 665 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 1860 | 0.020 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 2480 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 1195 | 0.020 |
Why?
|
| Pedigree | 1 | 2018 | 4648 | 0.020 |
Why?
|
| Postural Balance | 1 | 2014 | 620 | 0.020 |
Why?
|
| Transcription Factors | 2 | 2020 | 12207 | 0.020 |
Why?
|
| Epirubicin | 1 | 2009 | 80 | 0.020 |
Why?
|
| Life Expectancy | 1 | 1996 | 1184 | 0.020 |
Why?
|
| Hospitals | 1 | 2003 | 3952 | 0.020 |
Why?
|
| Drainage | 1 | 2015 | 1141 | 0.020 |
Why?
|
| Intelligence | 1 | 2014 | 920 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2016 | 1828 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2004 | 5102 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2004 | 4687 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 1998 | 1796 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 1998 | 2211 | 0.020 |
Why?
|
| Young Adult | 3 | 2021 | 56436 | 0.020 |
Why?
|
| Brain Injuries | 1 | 1999 | 2025 | 0.020 |
Why?
|
| Pregnancy | 1 | 2008 | 29142 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 2014 | 1670 | 0.020 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2009 | 731 | 0.020 |
Why?
|
| Disabled Persons | 1 | 1996 | 1212 | 0.020 |
Why?
|
| Length of Stay | 3 | 2004 | 6308 | 0.020 |
Why?
|
| Cause of Death | 1 | 1996 | 3584 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2009 | 692 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2009 | 1907 | 0.020 |
Why?
|
| Patient Selection | 1 | 2016 | 4216 | 0.010 |
Why?
|
| Hospital Records | 1 | 2004 | 95 | 0.010 |
Why?
|
| Risk | 1 | 1996 | 9685 | 0.010 |
Why?
|
| Dogs | 2 | 2000 | 3913 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 3133 | 0.010 |
Why?
|
| Quality of Life | 2 | 2014 | 12805 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1996 | 5396 | 0.010 |
Why?
|
| Age Factors | 2 | 2014 | 18367 | 0.010 |
Why?
|
| Electric Stimulation | 2 | 1997 | 1770 | 0.010 |
Why?
|
| Brain Mapping | 1 | 1997 | 6671 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2003 | 876 | 0.010 |
Why?
|
| Hippocampus | 1 | 2014 | 3676 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 12781 | 0.010 |
Why?
|
| Hospital Information Systems | 1 | 2004 | 395 | 0.010 |
Why?
|
| Disease Progression | 1 | 2018 | 13280 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2005 | 793 | 0.010 |
Why?
|
| Patient Discharge | 2 | 2004 | 3313 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 326 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2016 | 53280 | 0.010 |
Why?
|
| Survival Analysis | 2 | 2004 | 10250 | 0.010 |
Why?
|
| Databases, Factual | 2 | 2006 | 7730 | 0.010 |
Why?
|
| Glasgow Outcome Scale | 1 | 2000 | 109 | 0.010 |
Why?
|
| Myosin Light Chains | 1 | 2000 | 121 | 0.010 |
Why?
|
| Basilar Artery | 1 | 2000 | 200 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 7281 | 0.010 |
Why?
|
| Research Design | 1 | 2014 | 5987 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 1999 | 242 | 0.010 |
Why?
|
| Brain Stem | 1 | 2003 | 845 | 0.010 |
Why?
|
| Caspase 1 | 1 | 1999 | 224 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 4044 | 0.010 |
Why?
|
| Thalamus | 1 | 2003 | 1024 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 15538 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 1841 | 0.010 |
Why?
|
| Time Factors | 3 | 2004 | 40063 | 0.010 |
Why?
|
| Cognition | 1 | 2014 | 6765 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19907 | 0.010 |
Why?
|
| Radiography, Thoracic | 1 | 2003 | 1265 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2003 | 979 | 0.010 |
Why?
|
| Visual Fields | 1 | 2003 | 1049 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 1997 | 525 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2005 | 6461 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 2003 | 1357 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1263 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2000 | 1080 | 0.010 |
Why?
|
| Forearm | 1 | 1997 | 409 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2002 | 1000 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2000 | 1152 | 0.010 |
Why?
|
| Evoked Potentials, Motor | 1 | 1997 | 456 | 0.010 |
Why?
|
| Electrophysiology | 1 | 1997 | 1310 | 0.010 |
Why?
|
| Tongue | 1 | 1997 | 406 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 16687 | 0.010 |
Why?
|
| Risk Factors | 3 | 2005 | 72280 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 2003 | 2569 | 0.010 |
Why?
|
| Electromyography | 1 | 1997 | 1391 | 0.010 |
Why?
|
| Hand | 1 | 1997 | 884 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2003 | 12244 | 0.010 |
Why?
|
| Logistic Models | 1 | 2003 | 13409 | 0.000 |
Why?
|
| Longitudinal Studies | 1 | 2004 | 13990 | 0.000 |
Why?
|
| Seizures | 1 | 2000 | 2859 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15070 | 0.000 |
Why?
|
| Incidence | 1 | 2005 | 20945 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12355 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 9735 | 0.000 |
Why?
|
| Cross-Sectional Studies | 1 | 2004 | 25043 | 0.000 |
Why?
|
| Prognosis | 1 | 2003 | 29050 | 0.000 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4935 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2003 | 23337 | 0.000 |
Why?
|
| Liver | 1 | 1997 | 7472 | 0.000 |
Why?
|
| Rats | 1 | 1997 | 24273 | 0.000 |
Why?
|
| Neoplasms | 1 | 2009 | 21672 | 0.000 |
Why?
|
| Mice | 1 | 1999 | 81178 | 0.000 |
Why?
|